SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
芋圆不圆
Lv5
4
1440 积分
2022-09-08 加入
最近求助
最近应助
互助留言
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy
5天前
已完结
Mechanisms of drug resistance in HCC
9天前
已完结
Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
13天前
已完结
Protein induced by vitamin K absence or antagonist II: Experience to date and future directions
4个月前
已完结
Clinical utility of serum biomarkers for hepatocellular carcinoma
7个月前
已完结
Development and Validation of a Risk Prediction Model for Esophageal Squamous Cell Carcinoma Using Cohort Studies
1年前
已完结
939P Phase II study of pembrolizumab (pembro) and bavituximab (bavi) in advanced hepatocellular carcinoma (HCC)
1年前
已完结
O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma
1年前
已完结
Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study
1年前
已关闭
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
1年前
已完结
没有进行任何应助
感谢
13天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论